American Society of Clinical Oncology (ASCO)
3S Bio Announces 2026 Interim Results: Innovation-Driven, Win-Win Collaboration, and Sustainable Growth
SHANGHAI, Aug. 21, 2026 /PRNewswire/ -- 3S Bio (01530.HK) today announced its interim results for the first half of 2026. During the period, the Company recorded revenue of RMB 4.53 billion, representing a year-over-year growth of 3.9%. Net profit attributable to equity holders of the Company rea...
GSK's Blenrep (belantamab mafodotin) combinations approved in Singapore for treatment of relapsed/refractory multiple myeloma
* Two head-to-head phase III trials demonstrated superior efficacy, including overall survival versus a daratumumab-based triplet in DREAMM-7 * Blenrep, a first-in-class anti-BCMA ADC, could transform treatment as early as first relapse where additional effective treatment options are needed [...
CARsgen Therapeutics Announces 2026 Interim Results
SHANGHAI, Aug. 18, 2026 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, has announced its 2026 Interim Results. Business Highlights * Cash and cash equivalents were around RMB1,400 million as of June ...
Early Bird Tickets Now on Sale | ICOMIA & Sinoexpo Unveil 2027 ICOMIA World Marinas Conference (Shanghai) Preliminary Programme
SHANGHAI, Aug. 18, 2026 /PRNewswire/ -- The International Council of Marine Industry Associations (ICOMIA) and Conference hostSinoexpo Informa Markets are pleased to announce the Preliminary Conference Programme for theICOMIA World Marinas Conference 2027 (IWMC2027), taking place in Shanghai, Chi...
Kelun-Biotech Announces 2026 Interim Results
CHENGDU, China, Aug. 17, 2026 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech" or the "Company", Stock Code: 6990.HK) announces its unaudited consolidated results for the period ended 30 June 2026 (the "Reporting Period"). Key information is as follows: * Re...
Yochanra®, the World's First Innovative Drug to Overcome FGFR Inhibitor Resistance, Makes Its Global Debut in China
NANJING, China and GAITHERSBURG, Md., Aug. 7, 2026 /PRNewswire/ -- TransThera Sciences' Yochanra® is the first drug independently developed in China to address the longstanding global challenge of acquired resistance to FGFR inhibitor therapy in patients with cholangiocarcinoma. On 6 August 2026,...
Herbalgy Trophy Ignites Hong Kong as Football Fever Sweeps the City
Juventus Defeat Chelsea FC 1–0 "Goal-Getter Giveaway" Opens the Door to World-Class Football1, While 5 Children Fulfil Their Dreams as Player Mascots HONG KONG, Aug. 6, 2026 /PRNewswire/ -- The Herbalgy Trophy: Chelsea FC vs Juventus, the headline of the Hong Kong Football Festival 2026 proudly ...
Innovent Announces First Patient Dosed in Pivotal Registrational Study of IBI363/TAK-928 (PD-1/IL-2α-biased Bispecific Fusion Protein) in Combination with Bevacizumab in Late-Line Advanced Colorectal Cancer in China
SAN FRANCISCO and SUZHOU, China, Aug. 5, 2026 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures, and commercializes high-quality medicines for the treatment of oncology, autoimmune, cardiovascular and metabolic...
Gene Solutions Advances Precision Oncology Education in Malaysia with the ''Beyond Actionable'' Academy
At the Precision Oncology Academy 2026, leading international experts explored how insights from tumour DNA and RNA can reveal treatment opportunities, explain drug resistance, and translate into more confident treatment decisions to improve cancer care. KUALA LUMPUR, Malaysia, Aug. 4, 2026 /PRN...
CellOrigin Unveils Two Novel Solid-Tumor Cell Therapy Candidates at ASCO 2026, Partners with Walvax for In Vivo CAR Clinical Trial
HANGZHOU, China, July 31, 2026 /PRNewswire/ -- CellOrigin, a biotechnology company focused on next-generation in vivo and in vitro cell therapy technologies, has announced two major progresses in both research and strategic partnership. At the 2026 ASCO Annual Meeting, CellOrigin's scientific co...
Franchising & Licensing Asia 2026 Opens New Chapter Under MP, Strengthening Singapore's Position as Asia's Franchise and Licensing Hub
SINGAPORE, July 30, 2026 /PRNewswire/ -- Franchising & Licensing Asia (FLAsia)
2026 will launch on the13–15 August at the Marina Bay Sands Expo & Convention
Centre, marking a significant milestone as the event enters its 21st edition
under the organisation of MP Singapore.
AbbVie Announces Availability of ELAHERE® (mirvetuximab soravtansine) in Singapore for the Treatment of Platinum-Resistant Ovarian Cancer
* ELAHERE is the first and only antibody-drug conjugate (ADC) therapy approved specifically for patients with folate receptor alpha (FRα) positive, platinum-resistant high grade serous epithelial ovarian cancer, fallopian tube or primary peritoneal cancer, who have received one to three prior s...
Futu Unveils Major AI Upgrade, Making Professional Agentic Investing Accessible to All, Seize the Next Rally with FUTU AI
HONG KONG, July 16, 2026 /PRNewswire/ -- Futu Securities International (Hong Kong) Limited ("Futu") announced a comprehensive upgrade to its AI capabilities with the launch of "Expert" mode, its self-developed and built-in AI agent. Powered by a novel "Agentic AI + Skills" architecture that deli...
Kelun-Biotech Announces Phase III Study of Sacituzumab Tirumotecan (sac-TMT) in Combination with Pembrolizumab as First-Line Treatment for PD-L1-Negative Non-Squamous NSCLC Met Primary Endpoint
* As a head-to-head Phase III trial comparing sac-TMT plus pembrolizumab with the first-line standard of care (immunotherapy plus chemotherapy), OptiTROP-Lung06 demonstrated the superiority of replacing conventional pemetrexed/platinum chemotherapy with sac-TMT, with significantly prolonged PFS...
Gene Solutions' SPOT-MAS 10 Places Asia-Led Cancer Screening Innovation in the Global Spotlight
A blood-based cancer screening technology developed in Asia is gaining international attention after real-world data from more than 84,145 individuals were presented at ASCO Breakthrough 2026 and highlighted by the American Society of Clinical Oncology. For Gene Solutions, this milestone under...
Dx&Vx (DXVX) Partners with Over 40 Global Companies at BIO USA, "Focused Discussions on Overseas Out-Licensing Deals"
* Oral obesity drug with world-first mechanism of action unveiled, drawing strong on-site interest * Following successful Phase 1 clinical results, global discussions on OVM-200 expand * Meetings with over 40 companies, including major pharmaceutical companies, out-licensing now within reac...
Fox ESS Shines at The Smarter E Europe 2026 with Full-Ecosystem Offerings and AI-Driven Booth Experience
MUNICH, June 26, 2026 /PRNewswire/ -- Fox ESS, a global leader in renewable energy solutions, delivered a standout presence at The Smarter E Europe 2026. Making its European debut, the company unveiled a dynamic rebrand zone centered on its beloved mascot Maimai, offering interactive brand moment...
Yili Unveils AI-Powered Comic Series to Bring Dairy Supply Chain to Life at China Chain Expo
BEIJING, June 24, 2026 /PRNewswire/ -- Yili,
HDC 2026 Global Eco Summit: Huawei Ecosystem Fuels Partners' Growth in China and Cross-Border Success
DONGGUAN, China, June 19, 2026 /PRNewswire/ -- At the HDC 2026 Global Eco
Summit in Dongguan, Huawei convened global partners to explore how its
innovative technologies are reshaping digital interaction and business growth.
Revolutionizing Cancer Treatment: MAaGI Medical's "i" Series Multimodal Tumor Therapy Technique Globally Debuted
SHANGHAI, June 15, 2026 /PRNewswire/ -- In the summer of Suzhou, a distinguished gathering of eminent professionals convened. From June 11 to 14, 2026, the 20th Annual Scientific Meeting of the Asia Pacific Society of Cardiovascular and Interventional Radiology (APSCVIR 2026) was ceremoniously h...
Week's Top Stories
Most Reposted
Agoda Unveils Agoda Partner Portal as the Refreshed Platform's Role in Property Management Expands
[Picked up by 316 media titles]
2026-08-17 09:00
DayOne Launches Singapore's First Biological Data Center Prototype with Cortical Labs and NUS Medicine
[Picked up by 304 media titles]
2026-08-17 10:00
Intuitive Expands Manufacturing Footprint in Asia Pacific with New Facility in Penang, Malaysia
[Picked up by 291 media titles]
2026-08-17 14:19
Traveloka SEA Index Q2 2026: Southeast Asians Are Booking Longer Stays and the Region's Own Beaches Are Winning
[Picked up by 288 media titles]
2026-08-18 09:00
Miss World 2026 at Dragon Ocean Do Son: Elevating Vietnam's destination profile on the global stage
[Picked up by 283 media titles]
2026-08-19 17:43
Most Read
Agoda Unveils Agoda Partner Portal as the Refreshed Platform's Role in Property Management Expands
DayOne Launches Singapore's First Biological Data Center Prototype with Cortical Labs and NUS Medicine
H World Group Reports Strong Second-Quarter 2026 Performance and Announces New Shareholder Return Plan
